HIV/AIDS Data Hub for the Asia-Pacific Region
 
You are here: Regional Profiles Prevention of Parent to Child Transmission Displaying items by tag: Metadata
Displaying items by tag: Metadata
A key feature of the elimination initiative is its focus on improving the health and survival of women and children in the context of HIV/STIs.  This target underscores that PPTCT interventions do not end at delivery, and emphasizes the importance of linking HIV-infected children with lifesaving care and treatment.
 
MEASURE OF TARGET NUMERATOR DENOMINATOR METHOD OF MEASUREMENT
Percentage of HIV-infected children (aged 0-14 years) who are currently receiving ART
(UA Indicator)
Number of children who are receiving antiretroviral therapy in accordance
with the nationally approved treatment protocol (or WHO/UNAIDS standards)
at the end of the reporting period
Number of women Estimated number of children with advanced HIV infection Numerator: National programme records drawn from data
collected in ART registers at facilities

Denominator:  Estimated by the method recommended by the UNAIDS/WHO Reference Group on Estimates, Modelling and Projections using Spectrum software

 

ADDITIONAL INDICATORS FOR PROGRAMMATIC TARGET 8
No. Indicator What does it measure Numerator Denominator Method of Measurement
18 % of infants born to HIV-infected women receiving a virological test for HIV within 2 months of birth
(UA Indicator)
The extent to which infants born to HIV-infected women are tested within the first 2 months of life to determine their HIV status,
disaggregated by test results
Number of infants who received an HIV test within 2 months of birth, during the reporting period, disaggregated by test results Including positive, negative, indeterminate, and rejected for testing by the laboratory. Infants tested should only be counted once. The numerator should only include the most recent test result for an infant tested in the first 2 months of life, and not any earlier tests. Estimated number of HIV-infected  pregnant women giving birth in the last 12 months

Numerator:  Collected from databases held at Early Infant Diagnosis testing  laboratories 

Denominator:  Projection model  such as Spectrum*

 

 

20 Percentage of HIV-exposed infants who are receiving exclusive  breastfeeding, replacement feeding or mixed feeding at DPT3 visit (Infants will be aged around 3 months)
(UA Indicator)
Feeding of HIV-exposed infants, derived from 24-h recall, measured at the time of the third dose of diphtheria, pertussis and tetanus vaccine (DPT3) The numerators  capture feeding practices only for known HIV-exposed infants who visit a health facility at or around DPT3 visit, and are disaggregated as follows:
10a: Number exclusively breastfeeding
10b: Number receiving replacement feeding
10c: Number receiving mixed feeding
The number of HIV-exposed infants whose feeding practice has been assessed at
DPT3 visit.

Numerator: National programme records aggregated from stand-alone or integrated HIV-exposed registers

Denominator: Total number of exposed infants whose feeding was assessed.

21 Percentage of infants born to HIV- infected women who are started on co-trimoxazole prophylaxis within 2 months of birth
(UA Indicator)
The provision and coverage of co-trimoxazole prophylaxis for HIV-exposed infants in line with international guidelines Number of infants born to HIV-infected women started on co-trimoxazole prophylaxis within 2 months of birth in the past 12 months Estimated number of HIV-infected pregnant women who gave birth in the past 12 months

Numerator: National programme records aggregated from stand-alone or integrated HIV-exposed registers 

Denominator:  Projection model such as Spectrum*

* Multiply the number of women who gave birth in the past 12 months by the most recent national estimate of HIV prevalence in in pregnant women  (which can be derived from HIV sentinel surveillance in antenatal care clinics), if Spectrum projections are unavailable.

A key feature of the elimination initiative is its focus on improving the health and survival of women and children in the context of HIV/STIs.  This target underscores that PPTCT interventions do not end at delivery, and emphasize the importance of linking HIV-positive mothers to lifelong treatment and care.
 
MEASURE OF TARGET NUMERATOR DENOMINATOR METHOD OF MEASUREMENT
Percentage of eligible HIV-positive mothers still alive and known to be on treatment 12 months after ART initiation (among estimated eligible HIV-positive mothers in a given year) Number of HIV-infected pregnant women attending PPTCT services in the past 12 months assessed as eligible for ART (by either clinical or CD4 criteria) who were started and remain on ART at 12-months post-partum Estimated number of HIV-positive pregnant women eligible for ART (by either clinical or CD4 criteria) in a given year Numerator and Denominator: Antenatal care or other register for HIV-positive women, pre-ART or ART register depending on context; reporting form for special cohort analysis
ADDITIONAL INDICATORS FOR PROGRAMMATIC TARGET 7
No. Indicator What does it measure Numerator Denominator Method of Measurement
1 Percentage of HIV-infected pregnant women assessed for ART eligibility through either clinical staging or CD4 testing
(UA Indicator)
Coverage of eligibility assessment for ART among HIV-infected pregnant women, either by clinical staging criteria or by CD4 testing. Number of HIV-infected pregnant women attending services for PMTCT in the past 12 months assessed for eligibility for antiretroviral therapy by either clinical staging or CD4 testing, on site or by referral (Disaggregate by method of assessment) Estimated number of HIV-infected pregnant women in the past 12 months Numerator:  National programme data aggregate from health facility registers (ANC, or other register for HIV-positive women, pre-ART, or ART register
Denominator:  Projection model such as Spectrum*
2 Percentage of eligible HIV-infected pregnant women started on ART Coverage of ART among HIV-infected pregnant women who require treatment for their own health. Number of HIV-infected pregnant women attending services for PMTCT in the past 12 months started on antiretroviral therapy for their own health. Estimated number of HIV-infected pregnant women eligible for ART in the past 12 months Numerator and Denominator: National programme data aggregated from health facility (ANC, pre-ART, ART) register or reporting form

* Multiply the number of women who gave birth in the past 12 months by the most recent national estimate of HIV prevalence in in pregnant women  (which can be derived from HIV sentinel surveillance in antenatal care clinics), if Spectrum projections are unavailable.

Dramatic reductions in congenital syphilis infections will not be possible unless syphilis sero-positive pregnant women and their exposed infants receive effective treatment to reduce vertical transmission.
 
MEASURE OF TARGET NUMERATOR DENOMINATOR METHOD OF MEASUREMENT
Percentage of ANC attendees who were positive for syphilis (UA Indicator) Number of ANC attendees who tested positive for syphilis Number of ANC attendees who were tested for syphilis Numerator and Denominator: National programme data aggregated from health facility data (ANC register, reporting form)
Percentage of antenatal care attendees positive for syphilis who received treatment  
(UA Indicator)
Number of antenatal care attendees with a positive syphilis serology who received at least one dose of benzathine penicillin 2.4 mU IM Number of ANC attendees with a positive syphilis serology Numerator and Denominator: National programme data aggregated from health facility data (ANC or labour and delivery register; reporting form)
Percentage of infants born to syphilis seropositive women are treated appropriately Number of infants born to syphilis sero-positive women who received syphilis treatment to reduce congenital syphilis. Total number of live births to sero-positive pregnant women Numerator and Denominator: National Programme data aggregated from health facilty data (labour and delivery, post-partum registers)

There are no additional indicators for Programmatic Target 6.

Dramatic reductions in new paediatric HIV infections will not be possible unless pregnant women living with HIV and their exposed infants receive effective ARV regimens to reduce PTCT.  These data are collected from national programmes through the Universal Access (UA) and/or UNAIDS reporting processes.
 
MEASURE OF TARGET NUMERATOR DENOMINATOR METHOD OF MEASUREMENT
Percentage of HIV-infected pregnant women who received ARV drugs to reduce the risk of PTCT (UA Indicator) Number of HIV-infected pregnant women who received ARV to reduce MTCT during the preceding 12 months.  This includes:  
  1. ART for eligible women
  2. Maternal triple ARV prophylaxis;
  3. Maternal AZT, and
  4. Single-dose nevirapine only
    Disaggregate by  ARV option.
Estimated number of pregnant HIV-infected women in the preceding 12 months Numerator: National programme records aggregated from facility registers (ANC, labour and delivery, HIV care and treatment, post-partum care site)

Denominator:
Projection model such as Spectrum*
Percentage of infants born to HIV infected women who received ARV prophylaxis to reduce risk of peri-partum PTCT (UA Indicator) Number of infants born to HIV-infected women during the past 12months who were started on antiretroviral prophylaxis to reduce peri-partum parent-to-child-transmission Estimated number of live births to pregnant HIV-infected women in the past 12 months Numerator: National programme records aggregated from facility registers(labour and delivery, HIV care/treatment, postnatal care)

Denominator:
Projection model such as Spectrum*

* Multiply the number of women who gave birth in the past 12 months by the most recent national estimate of HIV prevalence in in pregnant women  (which can be derived from HIV sentinel surveillance in antenatal care clinics), if Spectrum projections are unavailable.

ADDITIONAL INDICATORS FOR PROGRAMMATIC TARGET 5
No. Indicator What does it measure Numerator Denominator Method of Measurement
13 % of infants born to HIV-infected mothers who are provided with ARV (maternal or infant) to reduce the risk of HIV transmission during breastfeeding period Progress in the prevention of PTCT in breastfeeding populations by the provision of ARVs to reduce the risk of HIV transmission during the breastfeeding period. Number of infants born to HIV-infected women who, during the past 12 months, are breastfeeding and protected by an antiretroviral intervention to reduce vertical transmission through breastfeeding, namely either maternal or infant ARVs Estimated number of infants born to HIV-infected women (HIV exposed infants) who are breastfeeding during the past 12 months Numerator and Denominator: Stand-alone or integrated HIV-exposed infant register; reporting form

The effectiveness of PMTCT and ECS interventions critically depends on the proportion of pregnant women who receive the results of their HIV and syphilis serology tests.  Women diagnosed in ANC setting can be linked to essential PMTCT and ECS services, as well as to life-saving treatment for their own health. These data are collected from national programmes through the Universal Access (UA) and/or UNAIDS reporting processes.
 
MEASURE OF TARGET NUMERATOR DENOMINATOR METHOD OF MEASUREMENT
Percentage of pregnant women who know their HIV status results (UA Indicator) Number of pregnant women who were tested for HIV and received results during pregnancy, during labour and delivery, and during the post-partum period (<72 hours), including those with previously known HIV status in the last 12 months Estimated number of total pregnant women in the last 12 months Numerator: National programme records aggregated from facility registers for ANC, labour and delivery and postpartum care.

Denominator:
Derived from a population estimate*
Percentage of women accessing ANC services who were tested for syphilis at
first ANC visit (UA Indicator)
Number of women attending first visit ANC services who were tested for
syphilis
Number of women attending first visit ANC services Numerator and Denominator: National programme records aggregated from facility registers for ANC

* Can be obtained from estimates of births from the central statistics office, United Nations Population Division, or pregnancy registration systems with complete data

ADDITIONAL INDICATORS FOR PROGRAMMATIC TARGET 4
No. Indicator What does it measure Numerator Denominator Method of Measurement
1 Percent of health facilities providing ANC services that also provide HIV testing and counselling for pregnant women  (UA Indicator) On-site availability of HIV testing at all health facilities that provide antenatal care Number of health facilities providing antenatal care services that offer HIV testing on site at the end of the reporting period Total number of health facilities providing antenatal care Numerator and Denominator: National programme records, e.g. list of facilities and available services
2 Percent of health facilities providing ANC services that also provide syphilis screening for pregnant women On-site availability of syphilis screening at all health facilities that provide antenatal care Number of health facilities providing antenatal care services that offer syphilis screening on site at the end of the reporting period Total number of health facilities providing antenatal care Numerator and Denominator: National programme records, e.g. list of facilities and available services

The effectiveness of PMTCT and ECS interventions critically depends on the proportion of pregnant women who access antenatal services and receive skilled attendant services at the time of labour and delivery.  These data are collected through the MDG monitoring process (MDG5). These data are often collected in routine programme monitoring and reporting systems. Data are also collected periodically in household surveys, including Demographic and Health Surveys (DHS), Reproductive Health Surveys (RHS), Fertility and Family Surveys (FFS), and are also included in the Multiple Indicator Cluster Surveys (MICS).
 
MEASURE OF TARGET NUMERATOR DENOMINATOR METHOD OF MEASUREMENT
Percentage of pregnant women attended by skilled personnel at least once in the antenatal period Number of women age 15-49 years who were attended at least once by skilled personnel during pregnancy in the 12 months preceding the survey Total number of women age 15-49 years with a live birth in the 12 months preceding the survey Numerator and Denominator: Review of national programme data or representative health survey(e.g. MICS)
Percent of deliveries attended by skilled birth attendants Number of women age 15-49 years with a live birth in the 12 months preceding the survey who were attended during childbirth by skilled health personnel Total number of women age 15-49 years with a live birth in the 12 months preceding the survey Numerator and Denominator: Review of national programme data or representative health survey (e.g. MICS)
ADDITIONAL INDICATORS FOR PROGRAMMATIC TARGET 2
No. Indicator What does it measure Numerator Denominator Method of Measurement
1 Percentage of pregnant women attended by skilled personnel at least 4 times during the antenatal period Access to antenatal services among all women Number of women age 15-49 years who were attended at least four times by any provider during pregnancy in the 12 months preceding the survey Total number of women age 15-49 years with a live birth in the 12 months preceding the survey Numerator and Denominator: Review of national  programme data or representative health survey (e.g. MICS)

Unmet need for FP is defined as the proportion of women of reproductive age (15-49 years) who are married or in union who do not want any more children or want to wait at least two years before having a baby, and yet are not using contraception. Reducing unmet need FP among women living with HIV reduces the number of unplanned pregnancies among HIV+ women, contributing to a reduction in potential new paediatric HIV infections.
 
MEASURE OF TARGET NUMERATOR DENOMINATOR METHOD OF MEASUREMENT
Unmet need for family planning among HIV-positive women of reproductive age (15–49 years) who are attending care and treatment services. Number of women of reproductive age living with HIV and attending HIV care and treatment services who either have an unmet need for family planning or an unintended pregnancy at the time of the assessment Total number of women of reproductive age (15–49) living with HIV who are attending HIV care and treatment services. Numerator and Denominator: Review of ART registries; Exit interviews with HIV-positive women in care if through special survey; national programme records
ADDITIONAL INDICATORS FOR PROGRAMMATIC TARGET 2
No. Indicator What does it measure Numerator Denominator Method of Measurement
1 Percentage of HIV service delivery points prepared to provide at least three family planning methods The necessary conditions for ensuring a minimum range of contraceptive methods at HIV care and treatment sites Number of HIV service delivery points prepared to provide (have unexpired stocks  and a trained provider available) ≥ 3 modern FP methods Number of HIV service delivery points assessed (All sites in country, or a selected sample) Numerator and Denominator: Representative survey conducted annually or every few years

Prevention of HIV in women of reproductive age (age 15-49) leads to a reduction in women living with HIV who may subsequently get pregnant, reducing the overall number of potential future paediatric HIV infections.
 
MEASURE OF TARGET NUMERATOR DENOMINATOR METHOD OF MEASUREMENT
HIV incidence among women aged
15-49 years (UNGASS Indicator)
Number of new HIV infections among women aged 15-49 years in a given calendar year Number of women 15-49 in the given calendar year, excluding the female HIV population in that year The baseline incidence and reduction in incidence in reproductive age women 15-49 should be modeled using the Spectrum software (see Annex 1).
ADDITIONAL INDICATORS FOR PROGRAMMATIC TARGET 1
No. Indicator What does it measure Numerator Denominator Method of Measurement
1 Percentage of key at-risk populations (KAPs) who received an HIV test in the last 12 months and who know their results
(UA/UNGASS indicator)
Assesses progress in implementing HIV testing and counselling among
KAPs. This indicator should be calculated separately for each population that is considered at-risk in a given country, (includes sex workers, people who inject drugs, men who have sex with men, and prisoners)
Number of KAP respondents who have been tested for
HIV during the last 12 months and who know the results.
Number of KAPs included in the sample. Numerator and Denominator:
Behavioural surveillance or other special surveys, sampled for specific KAPs can be used.
2 Percentage of Pregnant Women attending ANC whose partner was tested for HIV in the last 12 months*
(UA Indicator)
Assesses male involvement, which is important in the prevention of HIV infection. Measures percentage of pregnant women attending ANC whose male partner was tested during their female partner's pregnancy in the last 12 months. Number of pregnant women attending antenatal care whose male partner was tested in the past 12 months Number of pregnant women attending antenatal care in the past 12 months Numerator and Denominator: National programme records compiled from ANC registers.

*Alternatively, programmes may choose to focus on percentage of detected HIV-positive pregnant women whose partner was tested for HIV in the last 12 months.  The numerator is the number of pregnant HIV-positive women attending ANC whose male partner was tested in the last 12 months, and the denominator is the number of HIV-positive pregnant women attended ANC detected in the last 12 months.

The target of reducing the incidence of congenital syphilis addresses efforts to eliminate vertical transmission of syphilis2, 3.  This target directly addresses the public health issue of how well interventions are being provided to prevent new infant infections in women who are already syphilis sero-positive.

Measure of Target
Numerator Denominator Method of Measurement

The percentage of infants who have congenital syphilis should decrease as the coverage of interventions for ECS interventions increases.

Number of infants born to syphilis sero-positive mothers who have CS.
The percentage of infants who have congenital syphilis should decrease as the coverage of interventions for ECS interventions increases.


 

Browse indicator definitions/metadata by Prong/Programmatic target.

 

The target of reducing parent-to-child transmission (PTCT) to less than 5% addresses efforts to eliminate vertical transmission of HIV. This target directly addresses the public health issue of how well interventions are being provided to prevent new infant infections in pregnant women already infected with HIV.  The estimated risk of transmission without any interventions is around 35% (around 20-25% without breastfeeding)12. The regional target is to reduce over parent-to-child transmission to less than 5%, and a sub target of <2% transmission in non-breastfeeding settings.

Measure of Target
Numerator Denominator Method of Measurement

The denominator is not limited to only identified HIV-positive pregnant women.

In breastfeeding populations, PTCT should be assessed after cessation of breastfeeding.

The percentage of infants who are HIV-infected should decrease as the coverage of interventions for PPTCT and the use of more effective regimens increases


Number of infants born to HIV-infected mothers who are HIV-infected.

Number of all estimated HIV-positive pregnant women

ANC cohort of HIV+ mothers: 
In this method, programmes select a random sample of HIV-positive women from ANC files who gave birth earlier (e.g. in the past 12 months), and attempt to determine outcomes through data abstraction and linking, and intensive follow-up with post-partum and child records.  

Analysis of EID Data:
Countries should also analyse EID programme data to calculate the number of HIV-exposed infants with positive EID results.  These findings can be combined with estimates of the number of infants lost to follow up to get a national estimate of number of new infant HIV infections in a given year.

 

Browse indicator definitions/metadata by Prong/Programmatic target.

  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  Next 
  •  End 
  • »
Page 1 of 2